Avecho Biotechnology Limited (ASX:AVE)
0.0070
0.00 (0.00%)
Sep 19, 2025, 10:02 AM AEST
Avecho Biotechnology Revenue
Avecho Biotechnology had revenue of 560.07K AUD in the half year ending June 30, 2025, with 25.45% growth. This brings the company's revenue in the last twelve months to 1.38M, up 306.88% year-over-year. In the year 2024, Avecho Biotechnology had annual revenue of 1.13M with 139.19% growth.
Revenue (ttm)
1.38M
Revenue Growth
+306.88%
P/S Ratio
16.09
Revenue / Employee
92.04K
Employees
15
Market Cap
22.21M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.13M | 659.12K | 139.19% |
Dec 31, 2023 | 473.55K | -655.71K | -58.07% |
Dec 31, 2022 | 1.13M | 335.66K | 42.30% |
Dec 31, 2021 | 793.60K | 408.97K | 106.33% |
Dec 31, 2020 | 384.63K | -3.85M | -90.92% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 23.73B |
Pro Medicus | 212.98M |
Cochlear | 2.34B |
Sonic Healthcare | 9.65B |
Ramsay Health Care | 17.79B |
Ansell | 3.06B |
Telix Pharmaceuticals | 1.01B |
Mesoblast | 26.23M |